» Authors » Jiannong Liu

Jiannong Liu

Explore the profile of Jiannong Liu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 109
Citations 3861
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Johansen K, Wetmore J, Peng Y, Liu J, Weinhandl E, Gilbertson D
Am J Kidney Dis . 2021 Dec; 80(2):295-296. PMID: 34871699
No abstract available.
12.
Wetmore J, Johansen K, Liu J, Peng Y, Gilbertson D, Weinhandl E
J Am Soc Nephrol . 2021 Sep; 32(11):2948-2957. PMID: 34535558
Background: The COVID-19 pandemic caused major disruptions to care for patients with advanced CKD. Methods: We investigated the incidence of documented ESKD, ESKD treatment modalities, changes in eGFR at dialysis...
13.
Liu J, Laster A, Xu X, Guo H, Oates M, Gandra S
J Bone Miner Res . 2021 Sep; 36(12):2309-2316. PMID: 34490946
The 2020 American Association of Clinical Endocrinologists guidelines for assessing osteoporosis among postmenopausal women stratified postmenopausal women with osteoporosis to "high" and "very-high" fracture risk categories and recommended anabolic agents...
14.
Liu J, Guo H, Lin T, Wetmore J, Bradbury B, Gilbertson D, et al.
Pharmacoepidemiol Drug Saf . 2021 Aug; 31(2):141-148. PMID: 34363294
Purpose: Secondary hyperparathyroidism (SHPT) is common among dialysis patients, and calcimimetics are a mainstay of treatment. This study assessed whether cinacalcet use is associated with gastrointestinal bleeding in a large...
15.
Sing C, Lin T, Bartholomew S, Bell J, Bennett C, Beyene K, et al.
BMJ Open . 2021 Jul; 11(7):e047258. PMID: 34321298
Introduction: Hip fractures are associated with a high burden of morbidity and mortality. Globally, there is wide variation in the incidence of hip fracture in people aged 50 years and...
16.
Weinhandl E, Wetmore J, Peng Y, Liu J, Gilbertson D, Johansen K
J Am Soc Nephrol . 2021 Apr; 32(6):1444-1453. PMID: 33833076
Background: Reports from around the world have indicated a fatality rate of patients with coronavirus disease 2019 (COVID-19) in the range of 20%-30% among patients with ESKD. Population-level effects of...
17.
Johansen K, Chertow G, Foley R, Gilbertson D, Herzog C, Ishani A, et al.
Am J Kidney Dis . 2021 Mar; 77(4 Suppl 1):A7-A8. PMID: 33752804
No abstract available.
18.
Li S, Gong T, Kou C, Fu A, Bolanos R, Liu J
Clin Lymphoma Myeloma Leuk . 2021 Mar; 21(6):401-412.e24. PMID: 33658169
Background: Chronic kidney disease (CKD) is common in patients with multiple myeloma (MM) and is associated with a poor prognosis. We assessed CKD-associated clinical outcomes among elderly patients with MM...
19.
Li S, Peng Y, Liu J, Li S, Raskin L, Kelsh M, et al.
Curr Med Res Opin . 2020 Jul; 36(9):1519-1527. PMID: 32715807
Objective: To assess variations in hospitalizations, emergency department/observational (ED/OB) stays not resulting in hospitalization, reasons for hospitalization, and hospitalization discharge destinations after chemotherapy, information not provided as part of Oncology...
20.
Li S, Liu J, Gong T, Guo H, Gawade P, Kelsh M, et al.
J Geriatr Oncol . 2020 Jul; 11(8):1309-1315. PMID: 32624415
Purpose: Evaluate the relationship between duration of primary prophylactic short-acting granulocyte colony-stimulating factor (PP-sG-CSF) and risk of neutropenia-related hospitalization (NRH) in older patients receiving myelosuppressive chemotherapy. Methods: Using the Medicare...